• +1 700 888 1234

  • Effingerstrasse 40 3008 Bern Switzerland

Busy schedule planned for AGM 2024 in Zagreb

Lung Cancer Europe (LuCE) Annual General Meeting and General Assembly The Lung Cancer Europe (LuCE) AGM and General Assembly take […]

BMS Press Release is out now

Bristol Myers Squibb has released a new Press Release announcing that the European Medicines Agency (EMA) has validated the marketing authorization application for repotrectinib. Repotrectinib […]

LuCE attending the European Medicines Agency (EMA) in Amsterdam

November 14th – 15th in Amsterdam We are delighted to announce that Lung Cancer Europe (LuCE) is participating in a two-day meeting […]

Introducing our newest Member: Lungunion Austria

About the Organization Lungunion Austria  The Lungunion Austria is a patient organization (NGO and self-aid organization) for people with airway […]

Upcoming webinar “Coping with lung cancer diagnosis: Physical, social and emotional impact”

Join us for our upcoming webinar on “Coping with lung cancer diagnosis: Physical, social and emotional impact”.

🗓️ Date: 18 September 2023.

⏰ Time: 1-2 PM CET.

📍 Location: Online: LuCE social media channels.

World Conference on Lung Cancer 2023 – LuCE participation

LuCE will be actively participating in the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer #WCLC23 to be held in Singapore from 9-12 September 2023.